It is, however, anticipated that this effect could be observed only in menin-expressing TNBC as it has been described for castration-resistant prostate cancer cell lines that do not express an androgen receptor such as PC-3 (C.Cherif, Oncogene, in revision). The gene discussed is AR; the disease is prostate carcinoma.